Stock of the Month April 2025 - English

India’s pharma market is rapidly moving toward the $120 billion mark by 2030, drawing intense competition across the pharmaceutical value chain. As most Indian players focus on contract manufacturing with thin margins, our Stock of the Month stands out by consistently maintaining margins above 30%—a rare feat in the B2B generics space. In this video, we break down the structure of the pharma industry, analyze the company’s financials, business strategy, and how it stacks up against peers. Don’t miss this deep dive into a quietly strong player in a high-growth sector.